Showing results (111-120 of 191) with videos related to
Sort By:
Pageof 20
Translational Lung Cancer Research|May 9, 2022
Osimertinib as induction therapy for oligometastatic non-small cell lung cancer with EGFR mutation: a case reportHan Wu, Junwei Ning, Ziming Li, et al.Anticancer Research|December 3, 2024
Key Therapeutic Agents for Thymic Carcinoma in Real-world Clinical PracticeAkiko Tateishi, Yusuke Okuma, Yasushi Goto, et al.European Journal of Cancer (Oxford, England : 1990)|October 11, 2020
Impact of chemoradiotherapy on the immune-related tumour microenvironment and efficacy of anti-PD-(L)1 therapy for recurrences after chemoradiotherapy in patients with unresectable locally advanced non-small cell lung cancerMasayuki Shirasawa, Tatsuya Yoshida, Yuji Matsumoto, et al.Journal of Radiation Research|October 30, 2010
Acute adverse effects of radiation therapy on HIV-positive patients in Japan: study of 31 cases at Tokyo Metropolitan Komagome HospitalTakuya Kaminuma, Katsuyuki Karasawa, Nahoko Hanyu, et al.Lung Cancer (Amsterdam, Netherlands)|September 20, 2024
Association between lorlatinib blood concentration and adverse events and clinical impact of dose modificationYukiko Igawa, Tatsuya Yoshida, Reiko Makihara, et al.Cancer Immunology, Immunotherapy : CII|June 28, 2021
Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumabHitomi Jo, Tatsuya Yoshida, Hidehito Horinouchi, et al.Journal of Cancer Research and Clinical Oncology|April 26, 2024
Efficacy and safety of chemoimmunotherapy in advanced non-small cell lung cancer patients with antibiotics-induced dysbiosis: a propensity-matched real-world analysisKentaro Tamura, Yusuke Okuma, Shogo Nomura, et al.Japanese Journal of Clinical Oncology|February 11, 2026
Immune checkpoint inhibitors in nuclear protein in testis carcinoma treatment: evidence of limited clinical benefits from a case seriesTomoaki Nakamura, Tatsuya Yoshida, Akihiko Yoshida, et al.The Oncologist|September 28, 2014
A prospective study of shortened vitamin supplementation prior to cisplatin-pemetrexed therapy for non-small cell lung cancerYusuke Takagi, Yukio Hosomi, Kuniko Sunami, et al.Journal of Cancer Research and Clinical Oncology|July 25, 2020
Efficacy of anti-PD-1 antibodies in NSCLC patients with an EGFR mutation and high PD-L1 expressionKen Masuda, Hidehito Horinouchi, Midori Tanaka, et al.Pageof 20